Dr Ella Kleyman, PHARMD in Albrightsville, PA - Pharmacist

Dr Ella Kleyman, PHARMD is a Pharmacist based in Albrightsville, Pennsylvania. Dr Ella Kleyman is licensed to practice in New York (license number 045265) and her current practice location is 132 Parker Trail, Albrightsville, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (718) 333-3333.

NPI number for Dr Ella Kleyman is 1104162759 and her current mailing address is 132 Parker Trail, Albrightsville, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1104162759.

Contact Information

	Dr Ella Kleyman, PHARMD
	132 Parker Trail, Albrightsville, PA 18210-0504
	(718) 333-3333
	Not Available

Healthcare Provider's Profile

Full Name	Dr Ella Kleyman
Gender	Female
Speciality	Pharmacist
Location	132 Parker Trail, Albrightsville, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1104162759
Provider Enumeration Date: 12/28/2012
Last Update Date: 12/28/2012

Medical Identifiers

Medical identifiers for Dr Ella Kleyman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104162759	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	045265 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ella Kleyman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ella Kleyman, PHARMD 132 Parker Trail, Albrightsville, PA 18210-0504 Ph: () -	Dr Ella Kleyman, PHARMD 132 Parker Trail, Albrightsville, PA 18210-0504 Ph: (718) 333-3333

News Archive

Baylor receives patent for islet cell transplantation in patients with type1 diabetes, chronic pancreatitis

Baylor Research Institute has been awarded a patent from the U.S. Patent Office for a potential strategy to improve the outcomes of islet cell transplantation for patients with type 1 diabetes and chronic pancreatitis.

Study shows how certain woodrats put themselves on diet to avoid poisoning

Life is tough for woodrats in deserts of the U.S. Southwest. There are few plants for food, and those plants produce poison to deter rodents, insects and other animals. A new University of Utah study shows how certain woodrats put themselves on a diet to avoid poisoning: They sample a smorgasbord of toxic plants, eat smaller meals, increase time between meals and drink more water if it is available.

AAAOM, NCCAOM respond to report on cause of deaths due to improper acupuncture treatments

The American Association of Acupuncture and Oriental Medicine (AAAOM) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are collaborating to respond to a recent report by British professor Edzard Ernst, published in The Guardian, claiming improperly trained acupuncture treatments have been the cause of deaths over the past 45 years.

23andMe, Pfizer partner to explore genetic factors associated with IBD

23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD.

Dr Ella Kleyman, PHARMD - Pharmacist in Albrightsville, PA